Kunshan RiboQuark Pharmaceutical Technology Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7.42M

  • Investors
  • 3

Kunshan RiboQuark Pharmaceutical Technology General Information

Description

Operator of clinical stage pharmaceutical company. The company specializes in development of therapies to address medical needs and additionally offers a ocular neuroprotectant which is used for the prevention of hair loss.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kunshan
  • China
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Kunshan
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kunshan RiboQuark Pharmaceutical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 07-Jan-2014 $7.42M Completed Startup
1. Joint Venture 01-Sep-2012 Completed Startup
To view Kunshan RiboQuark Pharmaceutical Technology’s complete valuation and funding history, request access »

Kunshan RiboQuark Pharmaceutical Technology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BVCF Venture Capital Minority
Quark Pharmaceuticals Corporation Majority
Suzhou Ribobio Biotechnology Corporation Majority
To view Kunshan RiboQuark Pharmaceutical Technology’s complete investors history, request access »

Kunshan RiboQuark Pharmaceutical Technology FAQs

  • When was Kunshan RiboQuark Pharmaceutical Technology founded?

    Kunshan RiboQuark Pharmaceutical Technology was founded in 2012.

  • Where is Kunshan RiboQuark Pharmaceutical Technology headquartered?

    Kunshan RiboQuark Pharmaceutical Technology is headquartered in Kunshan, China.

  • What industry is Kunshan RiboQuark Pharmaceutical Technology in?

    Kunshan RiboQuark Pharmaceutical Technology’s primary industry is Drug Discovery.

  • Is Kunshan RiboQuark Pharmaceutical Technology a private or public company?

    Kunshan RiboQuark Pharmaceutical Technology is a Private company.

  • What is Kunshan RiboQuark Pharmaceutical Technology’s current revenue?

    The current revenue for Kunshan RiboQuark Pharmaceutical Technology is .

  • How much funding has Kunshan RiboQuark Pharmaceutical Technology raised over time?

    Kunshan RiboQuark Pharmaceutical Technology has raised $7.42M.

  • Who are Kunshan RiboQuark Pharmaceutical Technology’s investors?

    BVCF, Quark Pharmaceuticals, and Suzhou Ribobio Biotechnology have invested in Kunshan RiboQuark Pharmaceutical Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process